Shashwath A Meda, Madison M Dykins, Scot K Hill, Brett A Clementz, Sarah K Keedy, Jennifer E McDowell, Elena I Ivleva, Elliot S Gershon, Matcheri S Keshavan, Carol Tamminga, Godfrey D Pearlson
{"title":"Neural fingerprints of data driven cognitive subtypes across the psychosis spectrum: a B-SNIP study.","authors":"Shashwath A Meda, Madison M Dykins, Scot K Hill, Brett A Clementz, Sarah K Keedy, Jennifer E McDowell, Elena I Ivleva, Elliot S Gershon, Matcheri S Keshavan, Carol Tamminga, Godfrey D Pearlson","doi":"10.1038/s41398-025-03422-3","DOIUrl":null,"url":null,"abstract":"<p><p>Cognitive dysfunction is a prominent feature of psychotic spectrum disorders. Identifying neurocognitive subgroups and their neural underpinnings may help elucidate distinct pathophysiological mechanisms and inform targeted interventions. This study aimed to derive cognitive subtypes using latent profile analysis (LPA) of the Brief Assessment of Cognition in Schizophrenia (BACS) and investigate associated variations in resting-state functional connectivity among these cognitive profiles and biologically derived Biotypes. The BACS was administered to 1807 psychosis patients from the B-SNIP1 and 2 cohorts to perform LPA and identify cognitive subgroups. Regional homogeneity (ReHo), a measure of local functional connectivity, was computed from resting-state fMRI data in a subset (717 patients, 427 controls). Multivariate regression models examined associations between ReHo and cognitive LPA, Biotypes, and DSM diagnostic categories. LPA identified four cognitive profiles: cognitively comparable to controls (CCC), intermediate-1, intermediate-2, and severely impaired. These profiles showed unique dysconnectivity patterns, particularly within the striatal, default mode, salience, and executive control networks. The severely impaired group exhibited hyperconnectivity in basal ganglia and executive control networks. The intermediate groups showed default mode and salience network connectivity disruptions. The CCC group was the least impaired, with hyperconnectivity in sensory and auditory networks. Compared to Biotypes, LPA subgroups presented more domain-specific connectivity fingerprints. Psychosis patients exhibit heterogeneous cognitive profiles with divergent intrinsic functional dysconnectivity patterns. Cognitive LPA subgroups demonstrated more domain-localized neural signatures than DSM subtypes, potentially allowing for more targeted interventions. This approach highlights the utility of cognitive subtyping using standardized cognitive assessments in elucidating pathophysiological mechanisms in psychosis.</p>","PeriodicalId":23278,"journal":{"name":"Translational Psychiatry","volume":"15 1","pages":"224"},"PeriodicalIF":5.8000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12223097/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41398-025-03422-3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Cognitive dysfunction is a prominent feature of psychotic spectrum disorders. Identifying neurocognitive subgroups and their neural underpinnings may help elucidate distinct pathophysiological mechanisms and inform targeted interventions. This study aimed to derive cognitive subtypes using latent profile analysis (LPA) of the Brief Assessment of Cognition in Schizophrenia (BACS) and investigate associated variations in resting-state functional connectivity among these cognitive profiles and biologically derived Biotypes. The BACS was administered to 1807 psychosis patients from the B-SNIP1 and 2 cohorts to perform LPA and identify cognitive subgroups. Regional homogeneity (ReHo), a measure of local functional connectivity, was computed from resting-state fMRI data in a subset (717 patients, 427 controls). Multivariate regression models examined associations between ReHo and cognitive LPA, Biotypes, and DSM diagnostic categories. LPA identified four cognitive profiles: cognitively comparable to controls (CCC), intermediate-1, intermediate-2, and severely impaired. These profiles showed unique dysconnectivity patterns, particularly within the striatal, default mode, salience, and executive control networks. The severely impaired group exhibited hyperconnectivity in basal ganglia and executive control networks. The intermediate groups showed default mode and salience network connectivity disruptions. The CCC group was the least impaired, with hyperconnectivity in sensory and auditory networks. Compared to Biotypes, LPA subgroups presented more domain-specific connectivity fingerprints. Psychosis patients exhibit heterogeneous cognitive profiles with divergent intrinsic functional dysconnectivity patterns. Cognitive LPA subgroups demonstrated more domain-localized neural signatures than DSM subtypes, potentially allowing for more targeted interventions. This approach highlights the utility of cognitive subtyping using standardized cognitive assessments in elucidating pathophysiological mechanisms in psychosis.
期刊介绍：
Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod''s discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
